Treatment of invasive aspergillosis in kidney transplant recipients (a clinical case and a literature review) | CMAC

Treatment of invasive aspergillosis in kidney transplant recipients (a clinical case and a literature review)

Clinical Microbiology and Antimicrobial Chemotherapy. 2025; 27(2):140-149

​ Khostelidi S.N., Zaytsev M.A., Semenova E.V., Poboeva A.V., Pecherskaya E.A., Vladimirov P.A., Moshkevich I.R., Ignatyeva S.M., Frolova E.V., Bogomolova T.S., Vasilyeva N.V.
10.36488/cmac.2025.2.140-149
Aspergillus spp aspergillosis invasive aspergillosis immunosuppressive therapy kidney transplantation voriconazole
Section
Diseases and Pathogens
Type
Review
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2025; 27(2):140-149

Abstract

Invasive aspergillosis is a serious disease that can occur in organ transplant recipients. Most often, this complication develops in recipients of lung, heart, and liver transplants. Kidney transplant recipients are less likely to develop the disease. However, given that kidney transplantation is the most common type of transplantation, the number of patients with invasive aspergillosis in this category of patients is comparable to other types of internal organ transplantation. The article presents one case of invasive aspergillosis in kidney transplant recipient. An analysis of the literature was carried out, reflecting the features of the treatment of invasive aspergillosis in this category of patients.

Sofya N. Khostelidi

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia
Leningrad Regional Clinical Hospital, Saint-Petersburg, Russia

Zaytsev M.A.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia

Semenova E.V.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia
Leningrad Regional Clinical Hospital, Saint-Petersburg, Russia

Poboeva A.V.

Leningrad Regional Clinical Hospital, Saint-Petersburg, Russia

Pecherskaya E.A.

Leningrad Regional Clinical Hospital, Saint-Petersburg, Russia

Vladimirov P.A.

Leningrad Regional Clinical Hospital, Saint-Petersburg, Russia

Moshkevich I.R.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia
Leningrad Regional Clinical Hospital, Saint-Petersburg, Russia

Ignatyeva S.M.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia

Frolova E.V.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia

Bogomolova T.S.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia

Vasilyeva N.V.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia

  • 1. Federal State Budgetary Institution National Medical Research Center for Transplantology and Artificial Organs named after Academician V.I. Shumakov”. Available at: www.transpl.ru/about/statistics/. Accessed December 2024. Russian.
  • 2. Gavaldà J., Meije Y., Fortún J., Roilides E., Saliba F., Lortholary O., Muñoz P., Grossi P., Cuenca-Estrella M.; ESCMID Study Group for Infections in Compromised Hosts. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl. 7):27-48. DOI: 10.1111/1469-0691.12660
  • 3. Khostelidi S.N. Invasive mycoses in recipients of internal organ transplants (literature review). Problems of medical mycology. 2023;25(4):3-14. Russian. DOI: 10.24412/1999-6780-2023-4-3-14
  • 4. Pata R., Kristeva J., Kosuru B. Pneumonia in transplant recipients: a comprehensive review of diagnosis and management. Cureus. 2024;16(11):e73669. DOI: 10.7759/cureus.73669
  • 5. Elhaj Mahmoud D., Hérivaux A., Morio F. The epidemiology of invasive fungal infections in transplant recipients. Biomed J. 2024;47(3):100719. DOI: 10.1016/j.bj.2024.100719
  • 6. Patel M.H., Patel R.D., Vanikar A.V., Kanodia K.V. Invasive fungal infections in renal transplant patients: a single center study. Ren Fail. 2017;39(1):294-298. DOI: 10.1080/0886022X.2016.1268537
  • 7. López-Medrano F., Silva J.T., Fernández-Ruiz M., Carver P.L., van Delden C., Merino E., et al. Risk factors associated with early invasive pulmonary aspergillosis in kidney transplant recipients: results from a multinational matched case-control study. Am J Transplant. 2016;16(7):2148-2157. DOI: 10.1111/ajt.13735
  • 8. Ullmann A.J., Aguado J.M., Arikan-Akdagli S., Denning D.W., Groll A.H., Lagrou K., et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24:e1-38. DOI: 10.1016/J.CMI.2018.01.002
  • 9. Andreev S.S., Bronin G.O., Epifanova E.Yu. Advantages of early administration of antimycotic therapy in hematological patients. Oncohematology. 2024;19:99-112. Russian. DOI: 10.17650/1818-8346-2024-19-1-99-112
  • 10. Donnelly J.P., Chen S.C., Kauffman C.A., Steinbach W.J., Baddley J.W., Verweij P.E., et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71:1367-1376. DOI: 10.1093/cid/ciz1008
  • 11. Seok H., Huh K., Cho S.Y., Kang C.I., Chung D.R., Huh W.S., et al. Risk factors for development and mortality of invasive pulmonary Aspergillosis in kidney transplantation recipients. Eur J Clin Microbiol Infect Dis. 2020;39(8):1543-1550. DOI: 10.1007/s10096-020-03871-2
  • 12. Trnacevic S., Mujkanovic A., Nislic E., Begic E., Karasalihovic Z., Cickusic A., et al. Invasive aspergillosis after kidney transplant-treatment approach. Med Arch. 2018;72(6): 456-458. DOI: 10.5455/medarh.2018.72.456-458
  • 13. Heylen L., Maertens J., Naesens M., Van Wijngaerden E., Lagrou K., Bammens B., et al. Invasive aspergillosis after kidney transplant: case-control study. Clin Infect Dis. 2015;60:1505-1511. DOI: 10.1093/cid/civ103
  • 14. Sadon A.A., Al Otaibi T., Nair P. Pulmonary complications within the first year after renal transplantation. Egypt J Chest Dis Tuberc. 2020;69:739-746. DOI: 10.4103/ejcdt.ejcdt_220_19
  • 15. Li Z.W., Peng F.H., Yan M., Liang W., Liu X.L., Wu Y.Q., et al. Impact of CYP2C19 genotype and liver function on voriconazole pharmacokinetics in renal transplant recipients. Ther Drug Monit. 2017;39:422-428. DOI: 10.1097/FTD.0000000000000425
  • 16. Balcan B., Ozcelik U., Ugurlu A.O., Aydin M., Nalcaci S., Yarbug Karakayali F. Increased mortality among renal transplant patients with invasive pulmonary aspergillus infection. Prog Transplant. 2018;28:349-353. DOI: 10.1177/1526924818800044
  • 17. Luong M.L., Chaparro C., Stephenson A., Rotstein C., Singer L.G., Waters V., et al. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation. 2014;97(3):351-357. DOI: 10.1097/01.TP.0000437434.42851.d4
  • 18. Wójtowicz A., Gresnigt M.S., Lecompte T., Bibert S., Manuel O., Joosten L.A., et al. IL1B and DEFB1 polymorphisms increase susceptibility to invasive mold infection after solid-organ transplantation. J Infect Dis. 2015;211(10):1646. DOI: 10.1093/infdis/jiu636
  • 19. Favi E., Molinari P., Alfieri C., Castellano G., Ferraresso M., Cresseri D. Case report: eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-hus. Front Immunol. 2022;13:1073808. DOI: 10.3389/fimmu.2022.1073808
  • 20. Yu M., Liu M., Zhang W., Ming Y. Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation. Curr Drug Metab. 2018;19:513-522. DOI: 10.2174/1389200219666180129151948
  • 21. Kajiwara M., Masuda S. Role of mtor inhibitors in kidney disease. Int J Mol Sci. 2016;17:975. DOI: 10.3390/ijms17060975
  • 22. Meneghini M., Bestard O., Grinyo J.M. Immunosuppressive drugs modes of action. Best Pract Res Clin Gastroenterol. 2021;54-55:101757. DOI: 10.1016/j.bpg.2021.101757
  • 23. Muthu V., Gandra R.R., Dhooria S., Sehgal I.S. Prasad K.T., Kaur H., et al. Role of flexible bronchoscopy in the diagnosis of invasive fungal infections. Mycoses. 2021;64:668-677. DOI: 10.1111/myc.13263
  • 24. Kabir V., Maertens J., Kuypers D. Fungal infections in solid organ transplantation: an update on diagnosis and treatment. Transplant Rev. 2019;33:77-86. DOI: 10.1016/j.trre.2018.12.001
  • 25. Denning D.W. Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape. Int J Tuberc Lung Dis. 2021;25:525-536. DOI: 10.5588/ijtld.21.0053
  • 26. Gioia F., Filigheddu E., Corbella L., Fernández-Ruiz M., López-Medrano F., Pérez-Ayala A., et al. Invasive aspergillosis in solid organ transplantation: diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study). Mycoses. 2021;64(11):1334-1345. DOI: 10.1111/myc.13298
  • 27. Hoyo I., Sanclemente G., de la Bellacasa J.P., Cofán F., Ricart M.J., Cardona M., et al. Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients. Transpl Infect Dis. 2014;16:951-957. DOI: 10.1111/tid.12301
  • 28. Fernando M.E., Praveen R.V., Ishwarya A. Modulation of maintenance immunosuppression during infection in renal transplant recipients. Indian J Transplant. 2018;12:236-242. DOI: 10.4103/ijot.ijot_25_18
  • 29. Li Z., Denning D.W. The impact of corticosteroids on the outcome of fungal disease: a systematic review and metaanalysis. Curr Fungal Infect Rep. 2023;17(1):54-70. DOI: 10.1007/s12281-023-00456-2
  • 30. Raad I.I., El Zakhem A., El Helou G., Jiang Y., Kontoyiannis D.P., Hachem R. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 2015;45:283-288. DOI: 10.1016/j.ijantimicag.2014.08.012
  • 31. Barchiesi F., Mazzocato S., Mazzanti S., Gesuita R., Skrami E., Fiorentini A., Singh N. Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases. Liver Transplant. 2015;21:204-212. DOI: 10.1002/lt.24032
  • 32. Zhao Y.C., Sun Z.H., Li J.K., Liu H.Y., Zhang B.K., Xie X.B., et al. Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study. Front Pharmacol. 2024;15:1439232. DOI: 10.3389/fphar.2024.1439232
  • 33. Husain S., Camargo J.F. Invasive aspergillosis in solidorgan transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13544. DOI: 10.1111/ctr.13544
  • 34. Groll A.H., Townsend R., Desai A., Azie N., Jones M., Engelhardt M., et al. Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. Transpl Infect Dis. 2017;19(5):e12751. DOI: 10.1111/tid.12751
  • 35. Bauer A.C., Franco R.F., Manfro R.C. Immunosuppression in kidney transplantation: State of the art and current protocols. Curr Pharm Des. 2020;26:3440-3450. DOI: 10.2174/1381612826666200521142448
  • 36. Fernández-Ruiz M., Gioia F., Bodro M., Gutiérrez Martín I., Sabé N., Rodriguez-Álvarez R., et al. Isavuconazole versus voriconazole as the first-line therapy for solid organ transplant recipients with invasive aspergillosis: comparative analysis of 2 multicenter cohort studies. Transplantation. 2024;108(11):2260-2269. DOI: 10.1097/TP.0000000000005082
  • 37. Maertens J.A., Rahav G., Lee D.G., Ponce-de-León A., Ramírez Sánchez I.C., Klimko N., et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, noninferiority trial. Lancet. 2021;397:499-509. DOI: 10.1016/S0140-6736(21)00219-1
  • 38. Veselov A.V. Clinical pharmacology and practical aspects of the use of isavuconazole. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2023;25(4):379-394. Russian. DOI: 10.36488/cmac.2023.4.379-394
  • 39. Ganesh K., Abraham M. Abi, Kumar J.S., Simon S. Invasive fungal diseases in renal transplantation – case series. Indian J Transplant. 2021;15:169-175. DOI: 10.4103/ijot.ijot_28_20
  • 40. Neofytos D., Garcia-Vidal C., Lamoth F., Lichtenstern C., Perrella A., Vehreschild J.J. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response. BMC Infect Dis. 2021;21:296. DOI: 10.1186/s12879-021-05958-3
Views
0 Abstract
0 PDF
0 Crossref citations
Shared